Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

San Diego-based gene-sequencing giant Illumina got tangled in the United States’ trade tensions Tuesday as China placed the ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

以下简称Illumina）列入不可靠实体清单。 记者注意到，Illumina是一家基因测序试剂设备供应商，此前与国内部分基因测序公司有合作关系，与华大 ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results , but sales were flat year on year at $1.1 billion. On the ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

The Chinese government listed Illumina, whose global headquarters is in California, as an “unreliable entity” shortly after ...

Citi analyst Patrick Donnelly lowered the firm’s price target on Illumina (ILMN) to $130 from $165 and keeps a Neutral rating on the shares ...

Illumina Inc (ILMN) reports steady revenue growth and strategic advancements, while addressing competitive pressures and geopolitical risks.